Search

A new asymmetrically substituted ONOO Schiff base ligand N-(2′-hydroxy-1′-naphthylidene)-3-amino-2-naphthoic acid (nancH2) was prepared from the condensation of 2–hydroxy–1–naphthaldehyde and 3–amino–2–naphthoic acid. nancH2 reacts with Cu2(O2CMe)4·2H2O in the presence of Gd(O2CMe)3·6H2O to afford a uniform one-dimensional homometallic chain, [CuII(nanc)]n (1). The structure of 1 was elucidated via single crystal X-ray diffraction studies, which revealed that the Cu(II) ions adopt distorted square planar geometries and are coordinated in a tridentate manner by an [ONO] donor set from one nanc2− ligand and an O− of a bridging carboxylate group from a second ligand. The bridging carboxylato group of the nanc2− ligand adopts a syn, anti-η1:η1:μ conformation linking neighboring Cu(II) ions, forming a 1D chain. The magnetic susceptibility of 1 follows Curie–Weiss law in the range 45–300 K (C = 0.474(1) emu K mol-1, θ = +7.9(3) K), consistent with ferromagnetic interactions between S = ½ Cu(II) ions with g = 2.248. Subsequently, the data fit well to the 1D quantum Heisenberg ferromagnetic (QHFM) chain model with g = 2.271, and J = +12.3 K. DFT calculations, implementing the broken symmetry approach, were also carried out on a model dimeric unit extracted from the polymeric chain structure. The calculated exchange coupling via the carboxylate bridge (J = +13.8 K) is consistent with the observed ferromagnetic exchange between neighbouring Cu(II) centres.

The synthesis of a new {Ni8} cluster bearing tetrazolate- and azido-bridging ligands, and supported by chelating α-methyl-2-pyridine-methanol (mpmH) groups, is described herein. The reported compound has a unique trapezoidal prismatic topology, resulting from an unexpected in situ click reaction between the MeCN reaction solvent and the N3- ions under mild, room-temperature conditions. Such a click chemistry approach to the preparation of 0-D compounds is relatively unexplored and represents a fruitful strategy for the synthesis of new coordination clusters and molecule-based magnetic materials.

The synthesis of a new {Ni8} cluster bearing tetrazolate- and azido-bridging ligands, and supported by chelating α-methyl-2-pyridine-methanol (mpmH) groups, is described herein. The reported compound has a unique trapezoidal prismatic topology, resulting from an unexpected in situ click reaction between the MeCN reaction solvent and the N3- ions under mild, room-temperature conditions. Such a click chemistry approach to the preparation of 0-D compounds is relatively unexplored and represents a fruitful strategy for the synthesis of new coordination clusters and molecule-based magnetic materials.

Broadly neutralizing monoclonal antibodies protect against infection with HIV-1 in animal models, suggesting that a vaccine that elicits these antibodies would be protective in humans. However, it has not yet been possible to induce adequate serological responses by vaccination. Here, to activate B cells that express precursors of broadly neutralizing antibodies within polyclonal repertoires, we developed an immunogen, RC1, that facilitates the recognition of the variable loop 3 (V3)-glycan patch on the envelope protein of HIV-1. RC1 conceals non-conserved immunodominant regions by the addition of glycans and/or multimerization on virus-like particles. Immunization of mice, rabbits and rhesus macaques with RC1 elicited serological responses that targeted the V3-glycan patch. Antibody cloning and cryo-electron microscopy structures of antibody-envelope complexes confirmed that immunization with RC1 expands clones of B cells that carry the anti-V3-glycan patch antibodies, which resemble precursors of human broadly neutralizing antibodies. Thus, RC1 may be a suitable priming immunogen for sequential vaccination strategies in the context of polyclonal repertoires.

An effective HIV vaccine likely requires the elicitation of neutralizing antibodies (NAbs) against multiple HIV-1 clades. The recently developed cleavage-independent native flexibly linked (NFL) envelope (Env) trimers exhibit well-ordered conformation and elicit autologous tier 2 NAbs in multiple animal models. Here, we investigated whether the fusion of molecular adjuvant C3d to the Env trimers can improve B- cell germinal center (GC) formation and antibody responses. To generate Env-C3d trimers, we performed a glycine-serine- based (G4S) flexible peptide linker screening and identified a linker range that allowed native folding. A 30–60- amino- acid- long linker facilitates Env-to-C3d association and achieves the secretion of well-ordered trimers and the structural integrity and functional integrity of Env and C3d. The fusion of C3d did not dramatically affect the antigenicity of the Env trimers and enhanced the ability of the Env trimers to engage and activate B cells in vitro. In mice, the fusion of C3d enhanced germinal center formation, the magnitude of Env-specific binding antibodies, and the avidity of the antibodies in the presence of an adjuvant. The Sigma Adjuvant System (SAS) did not affect the trimer integrity in vitro but contributed to altered immunogenicity in vivo, resulting in increased tier 1 neutralization, likely by increased exposure of variable region 3 (V3). Taken together, the results indicate that the fusion of the molecular adjuvant, C3d, to the Env trimers improves antibody responses and could be useful for Env-based vaccines against HIV.

The employment of the [1+1] condensation approach for the preparation of new macrocyclic scaffolds (LN6 and LN3O3) towards high-performance Dy(III) single-molecule magnets (SMMs) with pseudo-D6h symmetry is described. Engineering of the macrocycles denticity from LN6 to LN3O3 leads to a mononuclear SMM with a large Ueff value of 1300 K. The experimental results are supported by ab initio calculations, which indicate relaxation of the magnetization via the second-excited state. [ABSTRACT FROM AUTHOR]

Controlling airborne transmitted disease remains a challenge to clinicians, healthcare administrators, and engineers. Engineering measures are critical to any infection control program but can require extensive installation procedures, may be expensive to maintain, and may not always demonstrate clinical or financial benefit. We determined the financial and carbon benefits of an engineering solution to combat air pollutants and to control airborne transmitted disease. We determined the costs of healthcare associated infections (HAIs), and the costs of installation, maintenance, energy demands, and carbon impacts of an ACTIVE Particle ControlTM (APC) air-purification system. In a 20 month study with over 65,000 patient days the significant reductions in HAIs resulted in significant financial, energy, maintenance, and carbon savings from this engineering solution. Positive clinical and financial outcomes are possible with novel air-purification solutions such as APC.